Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

VYNE Therapeutics Inc (NASDAQ: VYNE)

 
VYNE Technical Analysis
5
As on 18th May 2022 VYNE Share Price closed @ 0.40 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.66 & Strong Sell for SHORT-TERM with Stoploss of 7.99 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VYNE Share Price

Open 0.38 Change Price %
High 0.42 1 Day -0.01 -2.44
Low 0.38 1 Week 0.01 2.56
Close 0.40 1 Month -0.31 -43.66
Volume 365797 1 Year -6.40 -94.12
52 Week High 12.68 | 52 Week Low 0.37
 
NASDAQ USA Most Active Stocks
AMD 96.28 -6.04%
AAPL 140.82 -5.64%
BRQS 0.19 11.76%
SNDL 0.41 -6.82%
GNUS 0.78 13.04%
AGRI 2.92 8.96%
BBIG 3.05 6.64%
ENDP 0.62 -46.55%
NVDA 169.38 -6.82%
SOFI 7.23 2.55%
 
NASDAQ USA Top Gainers Stocks
NDRAW 0.03 200.00%
EYESW 0.48 92.00%
SMIHW 0.15 87.50%
ZJZZT 38.00 78.82%
THCAW 0.33 73.68%
WKSPW 0.63 57.50%
TMPMW 0.11 57.14%
BROGW 0.42 55.56%
PPHPR 0.14 55.56%
EFTRW 0.23 53.33%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
VENAW 0.05 -50.00%
ALACW 0.01 -50.00%
BTAQW 0.01 -50.00%
ENDP 0.62 -46.55%
MDGSW 0.21 -44.74%
ALACR 0.04 -42.86%
IKNX 19.52 -42.42%
NLITW 0.09 -40.00%
ROVRW 1.30 -34.34%
 
 
VYNE
Daily Charts		 VYNE
Intraday Charts		 Whats New @
Bazaartrend		 VYNE
Free Analysis
 
VYNE Important Levels Intraday
RESISTANCE0.48
RESISTANCE0.45
RESISTANCE0.44
RESISTANCE0.42
SUPPORT0.38
SUPPORT0.36
SUPPORT0.35
SUPPORT0.32
 
VYNE Target for Month May
Share
4th UP TARGET13.81
3rd UP TARGET9.51
2nd UP TARGET6.85
1st UP TARGET4.19
1st DOWN TARGET-3.39
2nd DOWN TARGET-6.05
3rd DOWN TARGET-8.71
4th DOWN TARGET-13.01
 
VYNE Weekly Target
4th UP TARGET1.71
3rd UP TARGET1.29
2nd UP TARGET1.03
1st UP TARGET0.77
1st DOWN TARGET0.03
2nd DOWN TARGET-0.23
3rd DOWN TARGET-0.49
4th DOWN TARGET-0.91
 
VYNE Target for Year 2022
4th UP TARGET25.18
3rd UP TARGET17.23
2nd UP TARGET12.32
1st UP TARGET7.41
1st DOWN TARGET-6.61
2nd DOWN TARGET-11.52
3rd DOWN TARGET-16.43
4th DOWN TARGET-24.38
 
 
VYNE Other Details
Segment EQ
Market Capital 65935104.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VYNE Address
VYNE
 
VYNE Latest News
 
Your Comments and Response on VYNE Therapeutics Inc
 
VYNE Business Profile
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older; and ZILXI for the treatment of inflammation lesions of papulopustular rosacea in adults. It is also developing FCD105, a topical combination foam that has completed Phase II clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in preclinical trial for the treatment of mild-to-moderate atopic dermatitis. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey. Address: 520 U.S. Highway 22, Bridgewater, NJ, United States, 08807
 
© 2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service